SUSTAINABILITY

Sustainable Development Strategy

The policy of the our Sustainable Development Strategy is to “accelerate the listing of new drugs to prolong the lives of patients and make society better. “Looking ahead, we will actively introduce new cancer drug research and development projects and continue to invest in the research and development of new cancer drugs.

Looking into the future, PharmaEngine will keep the integrity as the foundation, flexible operation and professional ability as the main focus, and human centered approach as the core, promote new drug R&D activities that align with the spirit of ESG, deepen international cooperation, leverage global R&D resources, accelerate new product development and commercialization, establish a globally competitive and diversified product portfolio, and set out to achieve the obligation of sustainable social responsibility ultimately.

Implementation plan and effect

The company has been deeply aware of its environmental sustainability integrity management and social responsibility as an enterprise management principle and core value that is recognized by the international community. To enable related stakeholders to understand more about the company, PharmaEngine has issued its first 2011 ESG Report (CSR Report) in 2012. The company commits to continually issuing its ESG reports, fully disclosing its great efforts in fulfilling its social responsibilities, and this serves as a practical way for PharmaEngine to continuously strive for achieving its integrity management, social responsibility and environmental sustainability.

The company's Sustainable Development responsibility units

The Sustainability Promotion Group is responsible for identifying sustainability issues concerning the Company’s operation and on which stakeholders focus, preparing short-term, mid-term, and long-term sustainable development plans and working directives, appropriating budget concerning respective organizations and sustainable development, planning and implementing annual plans and tracking their implementation effectiveness to make sure that the sustainable development strategy is fully consolidated as part of the daily operation of the Company.

• 2022/11/10

  Participated in the Sanzhi Repulse Bay coastal cleanup activity to support for” Do One Thing for the Tamsui River” initiative hosted by the Commonwealth Magazine

• 2021/09/29

  Hold a "Tamshui River Cultural and History Tour “ to support for ” Do One Thing for the Tamsui River”, initiative hosted by the Commonwealth Magazine

• 2020/11/18

  Participated in the supplies raising and food box packaging activities of the China Andrew Charity Association

• 2019/12/6

  Participated in the volunteer activities of the Genesis Social Welfare Foundation

• 2018/11/16

  Participated in the coastal cleanup activities in Jingshuiao

• 2017/9/22

  Support for Visually Impaired Care Foundation, Supply Donation and Volunteer Service - China Andrew Charity Association

• 2016/11/11

  Initiated invoice raising activity for Sunshine Social Welfare Foundation to help physical and psychological reconstruction and prevention services for burns and facial injuries with concrete actions

• 2015/10/23

  Engaged in coastal cleanup activity "North Coast and Guanyinshan National Scenic Area - Linshanbi"

• Sustainability Report 2022
• Sustainability Report 2021
• Sustainability Report 2020
• Corporate Social Responsibility Report 2019
• Corporate Social Responsibility Report 2018
• Corporate Social Responsibility Report 2017

Responsible unit for promoting corporate integrity management
The affairs related to corporate integrity management are carried out and promoted by the Corporate Development Department. "Ethical Business Management Work Group Meeting" may be convened when necessary, and will be convened and chaired by Vice President Chi-Hsing Chang. Based on the scope of duties and functions, all relevant departments will assist the Board of Directors and management officers to establish and supervise the implementation of ethical business management policy and prevention programs, and the relevant departments will also regularly report implementation status to the Board of Directors in each quarter.

The report of corporate integrity management
In order to prevent the risk of corruption and bribery, the company has established "Ethical Corporate Management Best Practice Principles" and "Procedures for Ethical Management and Guidelines for Conduct" as a code of conduct for directors, independent directors,senior managers and all practitioners.

All employees should comply with the “Code of Ethical Conduct”, and promise to obey the relevant rules and regulations to protect and maintain the company’s assets, rights and interests, and public images.  

The company classifies potential risks of its business operations, and based on the “probability of occurrence” and “degree of impact” of each type of risk, the relevant business department develops a corresponding plan for timely correction and improvement.

The Finance and Administrative Management Department will sort, collate, review the meeting minutes of "Ethical Business Management Work Group Meeting" and regularly report the relevant actions taken status or results to the Board of Directors.

Training Program execution status for the corporate integrity management
Advocacy and education of all employees is carried out by the Finance and Administrative Management Department, and the aforesaid division also collaborates with the HR Department to organize educational training related to ethical business management.

In 2019, 30 persons cumulatively received 358.5 hours of educational training related to ethical business management issues (including courses for legal compliance for ethical business management, drug safety and health management and inspections, accounting system and internal control etc.).

In 2020, *84 persons cumulatively received 190 hours of educational training related to ethical business management issues (including courses for legal compliance for ethical business management, drug safety and health management and inspections, accounting system and internal control etc.).

In 2021, 168 persons cumulatively received 465 hours of educational training related to ethical business management issues (including courses for legal compliance for ethical business management, drug safety and health management and inspections, accounting system and internal control etc.).

In 2022, 189 persons cumulatively received 427 hours of educational training related to ethical business management issues (including courses for legal compliance for ethical business management, drug safety and health management and inspections, accounting system and internal control etc.).